Association between oral antidiabetic medication and prostate cancer
10.3760/cma.j.cn115396-20241004-00304
- VernacularTitle:口服降糖药物与前列腺癌的相关性
- Author:
Guowei XIA
1
Author Information
1. 复旦大学附属华山医院泌尿外科，上海 200040
- Keywords:
Prostatic neoplasms;
Diabetes mellitus;
Antidiabetic medication;
Incidence;
Mortality
- From:
International Journal of Surgery
2024;51(10):649-654
- CountryChina
- Language:Chinese
-
Abstract:
Prostate cancer is recognized as a malignant tumor intricately linked to metabolic dysregulation, and its association with diabetes is notably complex. In recent years, there has been a surge in the development and clinical application of numerous oral antidiabetic medications, which have yielded promising results. Concurrently, an increasing body of research has uncovered the beneficial roles of these oral antidiabetic medications in the management of prostate cancer. This article provides a comprehensive review of the current research exploring the association between the use of oral antidiabetic medication and the treatment of prostate cancer.
